Imuran-induced regression of plasma cell tumor MOPC-315.
作者信息
Schlossberg M, Hollander V P
出版信息
Cancer Res. 1973 Aug;33(8):1953-6.
PMID:4720804
Abstract
摘要
相似文献
1
Imuran-induced regression of plasma cell tumor MOPC-315.硫唑嘌呤诱导浆细胞瘤MOPC - 315消退
Cancer Res. 1973 Aug;33(8):1953-6.
2
Transplantable mouse plasma cell tumors in experimental chemotherapy.
J Natl Cancer Inst. 1969 Jul;43(1):123-31.
3
Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.环磷酰胺治疗荷MOPC - 315肿瘤小鼠时给药时间的重要性。
Cancer Res. 1980 Jul;40(7):2135-41.
4
Chemotherapy and rate of kill of tumor cells in a mouse plasmacytoma.化疗与小鼠浆细胞瘤中肿瘤细胞的杀伤率
Cancer Res. 1974 Jul;34(7):1738-42.
5
The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.肿瘤生长动力学在晚期实体瘤“根治性”化疗方案制定中的应用。
Cancer Res. 1969 Dec;29(12):2384-9.
6
Genetic polymorphism and outcomes with azathioprine and 6-mercaptopurine.硫唑嘌呤和6-巯基嘌呤的基因多态性与治疗结果
Adverse Drug React Toxicol Rev. 2000 Dec;19(4):293-312.
7
[Immunosuppressive treatment in renal homologous transplantation].[肾同种移植中的免疫抑制治疗]
Minerva Chir. 1975;30(15-16):866-73.
8
When is too much enough?
Gastroenterology. 2006 Apr;130(4):1352-4. doi: 10.1053/j.gastro.2006.02.045.
9
Evaluation of a cooperative group human myeloma protocol using the MOPC 104E myeloma model.使用MOPC 104E骨髓瘤模型对一个合作组人类骨髓瘤方案进行评估。
Cancer Res. 1975 May;35(5):1309-13.
10
[Immunosuppressive therapy].[免疫抑制疗法]
Recenti Prog Med. 1970 Jan;48(1):1-18.
Zotero 插件